Drugs Made In America II Issues $300,000 Convertible Note for Merger Costs

Drugs Made In America Acquisition II Corp (DMII) has identified S.E.E Capitals Ltd. (Alpha Multi Family Office) as the financing partner for its $1.4 million convertible notes agreement, beginning with an initial $300,000 issuance. This capital injection is intended to cover professional expenses associated with the company's upcoming business combination. Notably, the company is currently undergoing a sponsor transition necessitated by the non-performance and legal issues of the current sponsor. The financing agreement includes provisions for a 35% conversion discount, which may lead to potential share dilution for existing holders upon maturity. This strategic shift aims to secure the necessary capital for legal and financial closing costs while stabilizing management. Despite these internal challenges, the move signals active progress toward finalizing the SPAC's merger goals.